NASSA, Giovanni
 Distribuzione geografica
Continente #
AS - Asia 7.152
NA - Nord America 4.966
EU - Europa 1.548
SA - Sud America 305
AF - Africa 64
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.046
Nazione #
HK - Hong Kong 5.285
US - Stati Uniti d'America 4.876
SG - Singapore 849
IT - Italia 467
CN - Cina 400
RU - Federazione Russa 241
VN - Vietnam 235
BR - Brasile 233
DE - Germania 202
UA - Ucraina 129
IE - Irlanda 83
FR - Francia 82
TR - Turchia 81
SE - Svezia 72
IN - India 68
KR - Corea 67
GB - Regno Unito 66
FI - Finlandia 61
CA - Canada 56
NL - Olanda 38
JP - Giappone 33
BD - Bangladesh 30
PL - Polonia 27
AR - Argentina 25
MX - Messico 24
AT - Austria 19
IQ - Iraq 18
SA - Arabia Saudita 18
ZA - Sudafrica 18
CO - Colombia 13
ES - Italia 13
CZ - Repubblica Ceca 12
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 10
ID - Indonesia 9
PH - Filippine 9
PK - Pakistan 9
EC - Ecuador 8
EG - Egitto 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CL - Cile 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
PY - Paraguay 4
TN - Tunisia 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PE - Perù 3
AL - Albania 2
BE - Belgio 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
LT - Lituania 2
LY - Libia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GM - Gambi 1
HN - Honduras 1
JM - Giamaica 1
KI - Kiribati 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
Totale 14.036
Città #
Hong Kong 5.278
Ann Arbor 752
Dallas 641
San Jose 519
Singapore 461
Chandler 369
Ashburn 303
Woodbridge 252
Princeton 200
Jacksonville 168
Wilmington 156
Houston 153
Salerno 93
Beijing 91
Council Bluffs 85
The Dalles 85
Munich 84
Dublin 78
Lauterbourg 67
Ho Chi Minh City 63
Los Angeles 59
Naples 52
Hanoi 49
Izmir 49
Santa Clara 47
New York 46
Andover 42
Nanjing 38
Dearborn 37
Boardman 34
Moscow 33
Tokyo 33
Dong Ket 32
Montreal 26
São Paulo 26
Pellezzano 25
Turku 25
Warsaw 24
Fairfield 23
Memphis 21
Frankfurt am Main 20
Shenyang 20
Orem 19
Atlanta 18
Nuremberg 18
Fisciano 17
London 17
Stockholm 17
Amsterdam 16
Changsha 16
Columbus 16
Milan 16
Mercato San Severino 15
Washington 15
Denver 14
Nürnberg 13
Poplar 13
Chicago 12
Hebei 12
Seattle 12
Boston 11
Brno 11
Brooklyn 11
Jinan 11
Da Nang 10
Düsseldorf 10
Guangzhou 10
Phoenix 10
San Francisco 10
Vienna 10
Ankara 9
Chennai 9
Redwood City 9
Sarno 9
Seoul 9
Tashkent 9
Falls Church 8
Helsinki 8
Johannesburg 8
Norwalk 8
Rio de Janeiro 8
Tianjin 8
Zhengzhou 8
Bogotá 7
Buffalo 7
Charlotte 7
Jeddah 7
New Delhi 7
Renton 7
Riyadh 7
Baghdad 6
Bologna 6
Calgary 6
Haiphong 6
Manchester 6
Mexico City 6
Nanchang 6
Philadelphia 6
Pisa 6
Pune 6
Totale 11.258
Nome #
Small non-coding RNA deregulation in endometrial carcinogenesis 1.117
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei 716
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 547
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer 499
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data 490
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 487
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 470
Host nasopharyngeal transcriptome dataset of a SARS-CoV-2 positive Italian cohort 451
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma 398
Small non-coding RNA transcriptomic profiling in adult and fetal human brain 336
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 241
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 232
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. 215
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 212
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 206
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 202
Non-coding RNA profiling in BRaFV600E-mutant cutaneous melanoma before and after Spry1 depletion 196
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 185
Small RNA profiling reveals deregulated PTEN/PI3K/Akt pathway in asthmatic bronchial smooth muscle cells. 183
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 180
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 179
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies 174
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 168
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 168
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 166
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 163
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 162
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 161
Global gene expression profile of normal and regenerating liver in young and old mice 157
Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma 155
Atrial myxomas arise from multipotent cardiac stem cells 152
Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands 151
Single-cell states in the estrogen response of breast cancer cell lines. 147
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 143
Global transcriptome profiles of Italian Mediterranean buffalo embryos with normal and retarded growth. 141
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells 141
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 141
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 139
MicroRNA (miRNA) and piwi-interacting RNA (piRNA) signature of human primary bronchial epithelial cells (PBEC) after exposure to mainstream cigarette smoke (MCS) 138
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 134
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 133
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 132
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 131
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 127
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 126
The "busy life" of unliganded estrogen receptors 126
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 126
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 125
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells 122
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors 120
HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis 119
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells 117
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 116
An overview of candidate therapeutic target genes in ovarian cancer 115
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 112
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei 110
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer 108
Lack of pathogenic mutations in six patients with MMPSI. 103
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 103
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer 103
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 101
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer 95
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 93
Whole Genome Sequence Dataset of Mycobacterium tuberculosis Strains from Patients of Campania Region 92
Regulation of metabolic reprogramming by long non-coding rnas in cancer 91
KCTD15 is overexpressed in human childhood B-cell acute lymphoid leukemia 86
BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target 85
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 83
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells 80
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer 79
Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells 78
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management 77
Caratterizzazione genomica e trascrittomica di tumori neuroendocrini gastro-enteropancreatici 73
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target 68
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer 66
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines 40
Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study 17
Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin 6
Editorial: Chromatin modifications and gene expression: from mechanisms to therapeutic implications in disease 2
Totale 14.329
Categoria #
all - tutte 37.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/2022375 10 0 5 1 34 6 3 9 48 42 56 161
2022/2023819 62 94 37 113 79 129 10 96 131 6 44 18
2023/2024424 30 42 34 16 31 74 59 14 9 23 20 72
2024/20251.189 20 11 7 37 80 132 233 87 195 73 176 138
2025/20269.098 837 2.521 2.878 351 534 267 576 113 418 451 119 33
Totale 14.329